In 1999 the World Health Organization launched the Pacific Program to Eliminate Lymphatic Filariasis as the Pacific arm of the Global Program, which aims to eliminate lymphatic filariasis as a Public Health problem by 2020. The two strategies to achieve this goal are:
- the interruption of transmission of filarial infection through either yearly rounds of Mass Drug Administration (MDA) using a combination of 2 drugs (Albendazole and Diethylcarbamazine, in the Pacific) for at least 5 years or through community use of DEC-salt
- to control the LF morbidity to alleviate and prevent the suffering and disability of affected individuals
The Pacific Program is coordinated by a WHO professional staff. In October 2006 the program took new directions under the leadership of the new coordinator and a number of activities have been implemented since then.